Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Retinitis Pigmentosa Read more
Surrozen Announces Strategic Partnership with Boehringer Ingelheim to Develop Wnt Agonist SZN-413 for People with Retinal Diseases Read more
Lilly receives FDA Fast Track designation for tirzepatide for the treatment of adults with obesity, or overweight with weight-related comorbidities Read more
Sanofi US enters into co-promotion agreement with Provention Bio, Inc. to launch teplizumab, an investigational disease-modifying therapy for type 1 diabetes Read more
The China NMPA Approves Selpercatinib for the Treatment of Patients with RET-driven Lung and Thyroid Cancers Read more
Many delegates already registered for Transdermal and Microneedle Drug Delivery conference in London Read more
Registration is now open for Pre-Filled Syringes and Injectable Drug Devices conference in Europe Read more
MilliporeSigma Announces a Boost in Commercial Capacity in France as Part of New Millipore CTDMO Services Read more